David Shaw’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-476,733
Closed -$77.5K 4848
2023
Q4
$77.5K Sell
476,733
-193,684
-29% -$64.3K ﹤0.01% 3994
2023
Q3
$297K Sell
670,417
-74,322
-10% -$33.9K ﹤0.01% 3620
2023
Q2
$275K Buy
744,739
+350,604
+89% +$299K ﹤0.01% 3630
2023
Q1
$717K Sell
394,135
-30,543
-7% -$66.4K ﹤0.01% 3371
2022
Q4
$879K Sell
424,678
-100,248
-19% -$317K ﹤0.01% 3536
2022
Q3
$1.58M Sell
524,926
-123,630
-19% -$438K ﹤0.01% 3212
2022
Q2
$2.08M Buy
648,556
+598,549
+1,197% +$3.24M ﹤0.01% 3037
2022
Q1
$323K Buy
50,007
+28,370
+131% +$257K ﹤0.01% 4614
2021
Q4
$290K Buy
+21,637
New +$238K ﹤0.01% 4694

Other funds holding HLTH

David Shaw's HLTH Position: Q1 2024 in Review

David Shaw sold out of Cue Health Inc. Common Stock (HLTH) in Q1 2024, closing a stake of 476,733 shares — an estimated $77.5K sold.

David Shaw first reported a position in HLTH in Q4 2021 and held it in 9 quarters. The position peaked at $2.08M in Q2 2022. 57 funds tracked by Wall St. Rank hold HLTH as of Q1 2024.

  • David Shaw reported no remaining Cue Health Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 476,733 Cue Health Inc. Common Stock shares in Q1 2024, an estimated $77.5K.
  • David Shaw first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • David Shaw's Cue Health Inc. Common Stock position peaked at $2.08M in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.